| Financial Year |
March 31 2023 |
| Monetary Funds |
18,604,632,000.00 |
| Held-for-trading Financial Assets |
14,131,505,000.00 |
| Notes Receivable |
335,153,000.00 |
| Accounts Receivable |
24,269,932,000.00 |
| Advances to Suppliers |
991,272,000.00 |
| Other Receivables |
2,782,058,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,360,307,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,327,735,000.00 |
| Other Current Assets |
7,691,773,000.00 |
| Total Current Assets |
105,183,441,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,655,414,000.00 |
| Long-term Equity Investment |
2,247,099,000.00 |
| Investment Properties |
149,234,000.00 |
| Fixed Assetes |
19,859,798,000.00 |
| Under-construction Projects |
4,059,491,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,643,482,000.00 |
| R&D expenses |
277,433,000.00 |
| Goodwill |
47,856,000.00 |
| Long-Term Deferred and Prepaid Expenses |
69,296,000.00 |
| Deferred Income Tax Assets |
2,798,285,000.00 |
| Other Non-Current Assets |
353,746,000.00 |
| Sub-Total of Non-Current Assets |
53,982,762,000.00 |
| Total Assets |
159,166,203,000.00 |
| Short-Term Loans |
4,000,459,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,923,532,000.00 |
| Accounts Payable |
22,110,418,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,754,022,000.00 |
| Taxes Payable |
1,237,938,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
75,315,000.00 |
| Other payables |
11,353,712,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,621,152,000.00 |
| Other Current Liabilities |
4,448,148,000.00 |
| Sub-Total of Current Liabilities |
63,085,118,000.00 |
| Long-term Loans |
24,779,473,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,519,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
211,629,000.00 |
| Deferred Income Tax Liabilities |
794,544,000.00 |
| Other Non-Current Liabilities |
7,465,000.00 |
| Sub-Total of Non-Current Liabilities |
28,609,409,000.00 |
| Total Liabilities |
91,694,527,000.00 |
| Paid-In Capital(Or Share Stock) |
8,486,602,000.00 |
| Capital Surplus |
5,284,025,000.00 |
| Surplus Reserve |
3,764,970,000.00 |
| LESS:Treasury Stock |
216,251,000.00 |
| Undistributed Profits |
50,656,936,000.00 |
| Minority Stockholder's Interest |
1,040,020,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
66,431,656,000.00 |
| Owner's Equity（Stockholder's Equity） |
67,471,676,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
159,166,203,000.00 |
